Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | +1.33% | +8.19% | -4.40% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.40% | 24.35M | |
+20.07% | 46.81B | |
-0.90% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.77% | 26.06B | |
-19.56% | 19.13B | |
+32.42% | 12.39B | |
+0.21% | 12.08B | |
-0.27% | 11.96B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Jefferies Downgrades Lumos Pharma to Hold From Buy With $7 Price Target